Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI1052

Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells.

D Ghigo, E Aldieri, R Todde, C Costamagna, G Garbarino, G Pescarmona, and A Bosia

Department of Genetics, Biology, and Biochemistry, University of Torino, 10126 Torino, Italy. ghigo@molinette.unito.it

Find articles by Ghigo, D. in: PubMed | Google Scholar

Department of Genetics, Biology, and Biochemistry, University of Torino, 10126 Torino, Italy. ghigo@molinette.unito.it

Find articles by Aldieri, E. in: PubMed | Google Scholar

Department of Genetics, Biology, and Biochemistry, University of Torino, 10126 Torino, Italy. ghigo@molinette.unito.it

Find articles by Todde, R. in: PubMed | Google Scholar

Department of Genetics, Biology, and Biochemistry, University of Torino, 10126 Torino, Italy. ghigo@molinette.unito.it

Find articles by Costamagna, C. in: PubMed | Google Scholar

Department of Genetics, Biology, and Biochemistry, University of Torino, 10126 Torino, Italy. ghigo@molinette.unito.it

Find articles by Garbarino, G. in: PubMed | Google Scholar

Department of Genetics, Biology, and Biochemistry, University of Torino, 10126 Torino, Italy. ghigo@molinette.unito.it

Find articles by Pescarmona, G. in: PubMed | Google Scholar

Department of Genetics, Biology, and Biochemistry, University of Torino, 10126 Torino, Italy. ghigo@molinette.unito.it

Find articles by Bosia, A. in: PubMed | Google Scholar

Published August 1, 1998 - More info

Published in Volume 102, Issue 3 on August 1, 1998
J Clin Invest. 1998;102(3):595–605. https://doi.org/10.1172/JCI1052.
© 1998 The American Society for Clinical Investigation
Published August 1, 1998 - Version history
View PDF
Abstract

Nitric oxide (NO) is a free radical involved in the regulation of many cell functions and in the expression of several diseases. We have found that the antimalarial and antiinflammatory drug, chloroquine, is able to stimulate NO synthase (NOS) activity in murine, porcine, and human endothelial cells in vitro: the increase of enzyme activity is dependent on a de novo synthesis of some regulatory protein, as it is inhibited by cycloheximide but is not accompanied by an increased expression of inducible or constitutive NOS isoforms. Increased NO synthesis is, at least partly, responsible for chloroquine-induced inhibition of cell proliferation: indeed, NOS inhibitors revert the drug-evoked blockage of mitogenesis and ornithine decarboxylase activity in murine and porcine endothelial cells. The NOS-activating effect of chloroquine is dependent on its weak base properties, as it is exerted also by ammonium chloride, another lysosomotropic agent. Both compounds activate NOS by limiting the availability of iron: their stimulating effects on NO synthesis and inhibiting action on cell proliferation are reverted by iron supplementation with ferric nitrilotriacetate, and are mimicked by incubation with desferrioxamine. Our results suggest that NO synthesis can be stimulated in endothelial cells by chloroquine via an impairment of iron metabolism.

Version history
  • Version 1 (August 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts